by Stacey Hawkins | May 5, 2020 | Oncology
Despite restricted access to parks and beaches due to the COVID-19 pandemic, people everywhere continue to seek solace in outdoor activities, enjoying a walk through the neighborhood or a cold drink on a hot afternoon in a sunny backyard. Fresh air and sunlight are... 
by Stacey Hawkins | Sep 26, 2019 | Oncology
The Elusive Cancer Vaccine Like unicorns, the fountain of youth and calorie-free chocolate, cancer vaccines have long proven elusive. But the emergence of a new crop of biotech companies makes it clear that a cancer vaccine is no myth. The latest advances in genomics... 
by Stacey Hawkins | Dec 10, 2015 | Other Diagnostics
The Latest In Cancer Diagnostics Hearing the words “it might be cancer” paired with your doctor’s perplexed look is enough to send shockwaves through your body. Getting to the heart of a diagnosis usually requires a surgical biopsy—removal and... 
by Stacey Hawkins | Nov 12, 2015 | Uncategorized
Oncolytic Viruses Make Their Debut Does a virus engineered to harness the immune system to fight cancer sound like a clever idea? Amgen (Thousand Oaks, CA) certainly thinks so, because their talimogene laherparepvec (T-Vec) recently earned an FDA approval to fight... 
by Stacey Hawkins | Jul 30, 2015 | Oncology
The Science Behind The Latest FDA Approval Strong Phase II data launched Novartis’ (Basel, Switzerland) Odomzo to an accelerated FDA approval for basal cell carcinoma last week. The company skipped Phase III testing for the skin cancer drug because 58% of...
